FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

109055007: Octreotide acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173590013 Octreotide acetate en Synonym Active Entire term case insensitive SNOMED CT core module
607692011 Octreotide acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide acetate Is a Octreotide false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Acetate false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Product containing octreotide false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Acetate compound false Inferred relationship Existential restriction modifier
Octreotide acetate Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier
Octreotide acetate Is a Cyclic peptide true Inferred relationship Existential restriction modifier
Octreotide acetate Is a Somatostatin analog true Inferred relationship Existential restriction modifier
Octreotide acetate Is modification of Octreotide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide 100micrograms/mL injection solution 1mL ampule Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) 5 ampoule 5 x 1ml ampoules Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/mL injection solution 1mL ampule Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Sun Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 200micrograms/mL injection solution 5mL vial Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (A A H Pharmaceuticals Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Doncaster Pharmaceuticals Ltd) 5 ampoule Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start